Leslie A Nangle

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 3

Top Topics

Vascular Endothelial Growth Factor

Locally Advanced

Cancer Stem Cells

Top Venues

Science translational medicine

Monoclonal antibodies in immunodiagnosis and immunotherapy

This page only lists publications with an associated author ORCID identifier.

Publications

Sarah Förster, Yeeting E Chong, David Siefker, Yvonne Becker, Ruizhi Bao, Erik Escobedo, Yang Qing, Kaitlyn Rauch, Luke Burman, Christoph Burkart, Philipp Kainz, Andrea Cubitt, Michael Muders, Leslie A Nangle
Development and Characterization of a Novel Neuropilin-2 Antibody for Immunohistochemical Staining of Cancer and Sarcoidosis Tissue Samples. Monoclonal antibodies in immunodiagnosis and immunotherapy 42 (5) (2023)
Zhiwen Xu, Hira Lal Goel, Christoph Burkart, Luke Burman, Yeeting E Chong, Alison G Barber, Yanyan Geng, Liting Zhai, Mengdie Wang, Ayush Kumar, Ann Menefee, Clara Polizzi, Lisa Eide, Kaitlyn Rauch, Justin Rahman, Kristina Hamel, Zachary Fogassy, Sofia Klopp-Savino, Suzanne Paz, Mingjie Zhang, Andrea Cubitt, Leslie A Nangle, Arthur M Mercurio
Inhibition of VEGF binding to neuropilin-2 enhances chemosensitivity and inhibits metastasis in triple-negative breast cancer. Science translational medicine 15 (694) (2023)
Zhiwen Xu, Hira Lal Goel, Christoph Burkart, Luke Burman, Yeeting E Chong, Alison G Barber, Yanyan Geng, Liting Zhai, Mengdie Wang, Ayush Kumar, Ann Menefee, Clara Polizzi, Lisa Eide, Kaitlyn Rauch, Justin Rahman, Kristina Hamel, Zachary Fogassy, Sofia Klopp-Savino, Suzanne Paz, Mingjie Zhang, Andrea Cubitt, Leslie A Nangle, Arthur M Mercurio
Inhibition of VEGF binding to neuropilin-2 enhances chemosensitivity and inhibits metastasis in triple-negative breast cancer. Science translational medicine 15 (694) (2023)